Selected Publications

Ivanciu L, Krohn L, Cevasco C, Deaton AM, Ward LD, LoGerfo PJ, Gansner JM, Camire RM, Slingsby MHL.: Hepatic plasminogen lowering with RNA interference for the treatment of bleeding disorders is unlikely to pose thrombotic risk based on UK Biobank analysis and mouse models of provoked thrombosis. European Hematology Association (EHA) Congress, Milan, Italy June 2025.

Ivanciu L and Camire RM: Blood Coagulation Factor IX: structure, function and regulation. IUBMB Life; "From DNA to protein: molecular mechanisms and tailored approaches to correct genetic defects associated with human disorders" 2025 Notes: co-corresponding author.

Poncz M, Zaitsev S, Ahn H, Kowalska MA, Bdeir K, Vladimirovich K, Ivanciu L, Camire RM, Cines DB, Stepanova V.: Packaging of supplemental urokinase into alpha-granules of the in vitro-grown megakaryocytic for targeted nascent clot lysis. Blood Advances 8(14): 3798-3809, Jul 2024.

Ivanciu L, Bos MHA, Camire RM: Enhanced activation of FVIII positively impacts clot formation in vivo using hemophilia A mice. Thrombosis & Hemostasis Summit of North America, Chicago, IL, Oral presentation Apr 2024.

Quin SM, Ivanciu L, Aymobil F, and Camire RM: A monoclonal antibody targeting human FV enhances thrombin generation and reduces bleeding in hemophilia A mouse model Annual Bleeding Disorders Conference, National Harbor, MD, Poster presentation Aug 2023.

Ivanciu L: Optimization of a tail vein transection bleeding model in hemophilia A. Journal of Thrombosis and Haemostasis 21(5): 1107-1108, May 2023.

Ivanciu L, Arruda V, and Camire RM: Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo. Blood 141(16): 2022-2032, Apr 2023.

Gordon D: NHF Fellowship: 50 Years of Insights, Innovation, and Breakthroughs. HemAware Dec 2022 Notes: Ivanciu L. interviewed.

Quin S, Ivanciu L, Davidson RJ, Ayombil F, and Camire RM: An antibody targeting human FV promotes thrombin generation and reduces bleeding in a hemophilic mouse model 64th American Society of Hematology Annual Meeting, New Orleans, LA, Oral presentation Dec 2022.

Quinn S, Ivanciu L, Davidson RJ, Ayombil F, Crosby JR, Revenko AS, Macleod AR, Monia BP, and Camire RM: Antibody GB5 targets human FV to enhance its activity and reduce bleeding in the context of hemophilia Gordon Research Conference on Hemostasis, Waterville Valley, NH, Poster presentation Aug 2022.